Davenport & Co’s Tandem Diabetes Care TNDM Stock Holding History

Davenport & Co’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,000	Closed	-$254K	–	703
2019 Q1	$254K	Sell	4,000 -2,000	-33%	-$105K	﹤0.01%	577
2018 Q4	$228K	Hold	6,000	–	–	﹤0.01%	571
2018 Q3	$257K	Sell	6,000 -23,400	-80%	-$817K	﹤0.01%	588
2018 Q2	$647K	Buy	29,400 +18,400	+167%	+$226K	0.01%	390
2018 Q1	$54.6K	Buy	+11,000	New	+$35.5K	﹤0.01%	678
2017 Q4	–	Sell	-12,500	Closed	-$91.3K	–	725
2017 Q3	$91.3K	Sell	12,500 -1,100	-8%	-$6.96K	﹤0.01%	661
2017 Q2	$109K	Buy	+13,600	New	+$126K	﹤0.01%	647

Other funds holding TNDM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Davenport & Co's TNDM Position: Q2 2019 in Review

Davenport & Co sold out of Tandem Diabetes Care (TNDM) in Q2 2019, closing a stake of 4,000 shares — an estimated $254K sold.

Davenport & Co first reported a position in TNDM in Q2 2017 and held it in 7 quarters. The position peaked at $647K in Q2 2018. 261 funds tracked by Wall St. Rank hold TNDM as of Q2 2019.

Davenport & Co reported no remaining Tandem Diabetes Care position as of Q2 2019 after selling out during the quarter.
Davenport & Co sold 4,000 Tandem Diabetes Care shares in Q2 2019, an estimated $254K.
Davenport & Co first reported a position in Tandem Diabetes Care in Q2 2017 and held it in 7 quarters.
Davenport & Co's Tandem Diabetes Care position peaked at $647K in Q2 2018.
261 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2019.

Based on Davenport & Co's 13F filing for Q2 2019, filed 10 Jul 2019.